Author

Elena Arconada‐Luque

University of Castilla-La ManchaORCID 0000-0002-2546-4157Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Antonio Fernández-Aramburo· 1 shared Atanasio PandiellaiD· 1 shared Azucena Esparı́s-OgandoiD· 1 shared Borja BelandiaiD· 1 shared Cesare SoffientiniiD· 1 shared Cristina Garnés‐GarcíaiD· 1 shared Elisabetta RovidaiD· 1 shared Francisco J. CimasiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Antonio Fernández-Aramburo

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

VCAN is essential for ERK5-driven tumorigenesis in soft tissue sarcoma

Jaime Jiménez‐Suárez, Francisco J. Cimas, José Joaquín Paricio, Borja Belandia, Yosra Berrouayel, Elena Arconada‐Luque, Sofía Matilla-Almazán, Cesare Soffientini, Stefano Percio, Silvia Redondo-García, Natalia García-Flores, Cristina Garnés‐García, Pablo Fernández‐Aroca, Juan Jesus Martinez-Gomez, Antonio Fernández-Aramburo, , Ricardo Sánchez‐Prieto

This study identifies VCAN as a novel transcriptional target of ERK5 and shows its essential role in ERK5-driven tumorigenesis in soft tissue sarcoma.

International Journal of Biological Sciences · Feb 4, 2026Peer-reviewedCancer Biology